SenoRx was founded in 1998 to design, develop,
manufacture and market minimally invasive devices for
the diagnosis and treatment of breast cancer. Since its founding, SenoRx has developed multiple, proprietary technology platforms and a unique product portfolio that address a range of diagnostic and therapeutic procedures. These products include the EnCor® Breast Biopsy System, the Contura® Multi-Lumen
Brachytherapy (MLB) Balloon Catheter for delivering radiation to
the tissue surrounding the lumpectomy cavity following
surgery for breast cancer, and SenoSonix®, which combines
ultrasound and vacuum assisted biopsy in one system.
It is the goal of SenoRx to become the leader in the
breast care market by offering products that dramatically
enhance patient outcomes. SenoRx has placed thousands
of its products in breast centers, hospitals, outpatient
centers, and radiation oncology centers across the
United States and Canada, and around the world.
SenoRx’s field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company’s
line of breast care products includes biopsy disposables,
biopsy capital equipment, diagnostic adjunct products
and therapeutic disposables. SenoRx is continuing development
of additional minimally invasive products for the diagnosis
and treatment of breast cancer.